This list is an analysis based on recent market events. It's not an investment recommendation.
Quratis Inc. engages in developing vaccines in South Korea. It is involved in developing QTP101, a vaccine for tuberculosis; QTP104, a next-generation mRNA vaccine; CPP (Cell Penetrating Peptide) Platform, a cell and bacterial penetration peptide drug delivery platform technology; and Peptide Nucleic Acid (PNA), a synthetic analogue of DNA in which the deoxyribose phosphate backbone. The company also offers drugs contract development and manufacturing services. Quratis Inc. was incorporated in 2016 and is based in Cheongju-si, South Korea.
FAQs
What is Quratis stock price today?▼
The current price of 348080.KQ is ₩3,485 KRW — it has decreased by -2.11% in the past 24 hours. Watch Quratis stock price performance more closely on the chart.
What is Quratis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Quratis stocks are traded under the ticker 348080.KQ.
Is Quratis stock price growing?▼
348080.KQ stock has risen by +2.5% compared to the previous week, the month change is a -9.01% fall, over the last year Quratis has showed a -55.28% decrease.
What is Quratis market cap?▼
Today Quratis has the market capitalization of 257.41B
What is Quratis revenue for the last year?▼
Quratis revenue for the last year amounts to 373.8M KRW.
What is Quratis net income for the last year?▼
348080.KQ net income for the last year is -26.27B KRW.
In which sector is Quratis located?▼
Quratis operates in the Other sector.
When did Quratis complete a stock split?▼
Quratis has not had any recent stock splits.
Where is Quratis headquartered?▼
Quratis is headquartered in Cheongju-si, South Korea.